Exclusive

Burger, fries, cola

Burger and a Coke? Fast food and fizzy drink changes ahead

McDonald’s and Coca-Cola usher in new ideas to pep-up, perk-up and slim-down the customers in the queue By HAL WILLIAMS JUNK food has come a long...
Emirates Airbus A380

Emirates order keeps A380 in production

Giant airliner’s future had been under a cloud The Emirates airline has pulled the Airbus A380 back from an early grave with an order for...
Tesla Model S P85D

Clean? Check. Cool? Check. But e-vehicles have poke too

Hot new electric wheels offer more than just zero emissions – the latest offerings have some serious grunt, too By HAL WILLIAMS THE TIMES are changing,...
Indra Nooyi

Passing the Pepsi test

The jewel in the crown of PepsiCo is celebrating a decade at the pinnacle of one the world’s most iconic companies – a brand...
Bitcoin with credit card and POS terminal

Lloyds Banking Group shuts down all crypto credit card transactions

Are we witnessing the murder of Bitcoin? Knives are out for the biggest and (so far) bestest crypto on the block. HAL WILLIAMS looks...
Reserve Bank of India

Indian Summer On The Horizon

Investors had been keeping their distance from India this last 12 months as New Delhi's business hubs looked like being on the brink of...
Yemeni Military Shibam

Drug cartels, weapons, banks and the Greenback — illicit trade continues,...

Major banks are unwittingly laundering drug money to fund international arms deals, a former US Senate candidate tells BV editor HAL WILLIAMS US BUSINESS intelligence...
Amazon

Amazon Overflowing Into New Premises

As if Amazon’s current HQ wasn’t colossal enough, the internet-based retailer is in the market for a second mega-HQ big enough for 50,000 staff....
Samsung Galaxy

Case Study: Samsung: Learning a lesson in customer response

By Tony Lennox UNTIL the moment Gerald Ratner stood up to deliver an after-dinner speech to the Institute of Directors at the Albert Hall in...
Gene therapy

Merger brings gene therapy aid for infants closer to production

FDA approves ‘breakthrough therapy’ designation for novel treatment NOVARTIS has announced a multi-billion dollar agreement and plan of merger with AveXis to acquire the US-based...